Atlas Trials

Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Clinical trial NCT03735589 · WITHDRAWN

Trial details

NCT number
NCT03735589
Sponsor
Roswell Park Cancer Institute
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Stage II Fallopian Tube Cancer AJCC v8Stage II Ovarian Cancer AJCC v8Stage II Primary Peritoneal Cancer AJCC v8Stage IIA Fallopian Tube Cancer AJCC v8Stage IIA Ovarian Cancer AJCC v8Stage IIA Primary Peritoneal Cancer AJCC v8Stage IIB Fallopian Tube Cancer AJCC v8Stage IIB Ovarian Cancer AJCC v8Stage IIB Primary Peritoneal Cancer AJCC v8Stage III Fallopian Tube Cancer AJCC v8Stage III Ovarian Cancer AJCC v8Stage III Primary Peritoneal Cancer AJCC v8
Start date
2023-12-15
Primary completion
2025-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.